The Wall Street Journal
Novartis to License Drug From China’s Abogen in Up to $7.8 Billion Deal — Abogen said its lead drug has potential to transform the treatment landscape for patients with autoimmune diseases.
Volvo Car Pulls Guidance as Chinese Auto Market Worsen — The carmaker said further deterioration in the Chinese market and slow recovery in the U.S. led to lower-than-expected third-quarter sales.
China’s Peak-Season Auto Sales Growth Disappoints — Chinese electric-
Subscribe or login to read the rest.
Subscribers get full access to:
- Exclusive longform investigative journalism, Q&As, news and analysis, and data on Chinese business elites and corporations. We publish China scoops you won't find anywhere else.
- A weekly curated reading list on China from Andrew Peaple.
- A daily roundup of China finance, business and economics headlines.
We offer discounts for groups, institutions and students. Go to our
Subscriptions page for details.
Includes images from Depositphotos.com
